Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-35755-z
Abstract: Zika virus (ZIKV) is a major public health concern due to the risk of congenital Zika syndrome in developing fetuses and Guillain-Barre syndrome in adults. Currently, there are no approved vaccines available to protect against… read more here.
Keywords: vaccine; zikv; prm; ad4 prm ... See more keywords